-
公开(公告)号:CA2260756C
公开(公告)日:2007-07-10
申请号:CA2260756
申请日:1997-04-04
Applicant: MEDTRONIC INC
Inventor: MORISSETTE JOSEE , STOKES KENNETH B
Abstract: The present invention provides delivery systems for delivering conduction protein genetic material to cardiac cells in localized areas of the heart to improve the conductance therein. More specifically, there is provided a system for delivering connexin proteins or nucleic acid molecules encoding connexin proteins to a site in the heart which has been determined by mapping procedures to have a conduction disturbance. For cases where conduction is impaired, selected genetic materi al is delivered by Applicants' delivery system to cells around the disturbance area, in order to enhance overall conductivity patterns; in other cases, genetic material is selected to slow conduction in affected areas, so as to prevent, e.g., brady-tachy syndrome.
-
公开(公告)号:CA2518374A1
公开(公告)日:2004-09-23
申请号:CA2518374
申请日:2004-03-08
Applicant: MEDTRONIC INC
Inventor: EBERT MICHAEL J , HOBOT CHRISTOPHER M , STOKES KENNETH B
Abstract: A biostable polymeric substrate of an implantable medical device unit includ es a demand-release bioactive composition including one or more bioactive agent s covalently bound to surface-modifying end groups of the substrate. Certain cellular activities, in proximity to the polymeric substrate, release substances reacting with the end groups such that the end groups release the one or more bioactive agents, which modify the certain cellular activities.
-
公开(公告)号:DE69514126T2
公开(公告)日:2000-09-28
申请号:DE69514126
申请日:1995-02-01
Applicant: MEDTRONIC INC
Inventor: MCVENES RICK D , POHNDORF PETER J , STOKES KENNETH B , PROCTOR KEITH J
IPC: A61N1/05
Abstract: A chronic myocardial pacing lead for the delivery of stimulation energy to and the sensing of electrical signals from the myocardium of a human heart. In one embodiment the lead is bipolar, having a sleeve electrode (20) implanted into the myocardium and a pad electrode (15) positioned on the epicardium. The lead includes a drug for delivery through the sleeve electrode to the myocardium. The disclosed lead is highly flexible to minimize tissue reaction, this permits the lead to offer relatively low pacing thresholds, high impedance, and excellent sensing in a configuration which is relatively easy to implant.
-
44.
公开(公告)号:CA2261022A1
公开(公告)日:1998-01-22
申请号:CA2261022
申请日:1997-04-04
Applicant: MEDTRONIC INC
Inventor: MORISSETTE JOSEE , STOKES KENNETH B
Abstract: The present invention provides delivery systems for delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.
-
公开(公告)号:AU682090B2
公开(公告)日:1997-09-18
申请号:AU1515395
申请日:1994-12-19
Applicant: MEDTRONIC INC
Inventor: STOKES KENNETH B , PROCTOR KEITH J , MCVENES RICK D
-
公开(公告)号:AU2096695A
公开(公告)日:1995-10-03
申请号:AU2096695
申请日:1995-03-06
Applicant: MEDTRONIC INC
Inventor: BREYEN MARK D , LESSAR JOSEPH F , STOKES KENNETH B , UPTON JAMES E , ISTEPHANOUS NAIM S , MILLER JENNIFER P
IPC: A61N1/05
-
公开(公告)号:AU1515395A
公开(公告)日:1995-08-21
申请号:AU1515395
申请日:1994-12-19
Applicant: MEDTRONIC INC
Inventor: STOKES KENNETH B , PROCTOR KEITH J , MCVENES RICK D
-
公开(公告)号:CA2182609A1
公开(公告)日:1995-08-10
申请号:CA2182609
申请日:1994-12-19
Applicant: MEDTRONIC INC
Inventor: STOKES KENNETH B , PROCTOR KEITH J , MCVENES RICK D
IPC: A61N1/05
Abstract: An implantable lead (10) for establishing electrical contact between a medical device and body tissue, in which an active fixation mechanism (18) secures the lead (10) in place while allowing a distal electrode (14) on the lead to mechanically "float" with respect to the body tissue. In one embodiment, the active fixation mechanism (18) comprises a curved hook disposed on the lead (10) at a point spaced proximally back from the distal end (14) of the lead (10). The curved hook (18) defines a helix around at least a portion of the lead's circumference. A hollow introducer needle is slidably disposed on the lead (10). The hollow needle is provided with a longitudinal slit in a distal section of its length, such that the distal section of the needle can be advanced over the distal end (14) the lead (10), past the fixation hook, which is received in the longitudinal slit. With the needle slid over the distal end (14) of the lead (10), the needle is stabbed angentially into an implant site, bringing the fixation hook (18) proximal to the surface of the body tissue. Then, the needle is twisted (bringing about a twisting of the lead (10)), causing the curved fixation hook (18) to pierce and engage the body tissue, securing the lead (10) in place. Then the needle is withdrawn from the body tissue and removed from the lead (10). In an alternative embodiment, the lead (10) can be placed by an endocardial approach using a flexible cannula with a longitudinally slotted tip.
-
49.
公开(公告)号:CA2023703C
公开(公告)日:1995-05-16
申请号:CA2023703
申请日:1990-08-21
Applicant: MEDTRONIC INC
Inventor: DI DOMENICO EDWARD D , HOBOT CHRISTOPHER M , STOKES KENNETH B , COURY ARTHUR J , DOAN PHONG D , SANDSTROM RICHARD D
Abstract: A cardiac pacing lead or other stimulation lead carrying a steroid compounded within a polymer matrix. The steroid is dispersed in thermoplastic or thermoset polyurethane or polyurea forming monomers or prepolymers. The mixture is then chain extended by addition of the appropriate difunctional or multifunctional isocyanate, hydroxyl or amine curing agent to form a solid polymer. The resulting formulation is molded or cast into a desired shape, and incorporated in the distal end of a medical electrical lead, adjacent to or within the electrode. In a preferred embodiment, the medical lead employs an extendable helix which is screwed into body tissue, and the polymer containing the drug takes the form of a generally dimensionally stable annular member mounted to the lead, encircling the helix.
-
公开(公告)号:CA2093940A1
公开(公告)日:1993-11-07
申请号:CA2093940
申请日:1993-04-13
Applicant: MEDTRONIC INC
Inventor: STOKES KENNETH B , COMBEN RICHARD H
Abstract: TOOL-LESS TREADED CONNECTOR ASSEMBLY A lead connection suitable for use in connecting a flexible coiled lead to an implantable device. The implantable device is provided with a threaded projection having an outer diameter sized with respect to the inner diameter of the lead's conductor coil to provide a secure interconnection therewith when attached thereto. The threaded projection is disposed on top and around a feedthrough pin projecting out of the implanted device's hermetic canister. The threaded projection is screwed into the conductor coil establishing sound electrical contact between the projection and the conductor. A strain relief collar surrounds the post and lead, and a twist-and-pull type connecting ring surrounds the base of the strain relief collar. The connecting post is prevented from being unscrewed from the conductor coil, since an unscrewing motion tends to tighten the conductor coil around the threaded post. Since no connecting structure is required at the connecting end of the lead, the lead can be cut to any appropriate length at the time of implant, thereby eliminating problems with excess implanted lead. If disconnection is required, the lead may be simply cut off just beyond the threaded connecting post, or the post may be unscrewed by applying inward radial or circumferential pressure on the conductor coils. In an alternative embodiment, the threaded projection is replaced with a tapered triangular post with either smooth or toothed edges, which is inserted into the coiled conductor lead.
-
-
-
-
-
-
-
-
-